_id

690dad60ccc777a4e85d0a06

Ticker

ALLO

Name

Allogene Therapeutics Inc

Exchange

NASDAQ

Address

210 East Grand Avenue, South San Francisco, CA, United States, 94080

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://allogene.com

Description

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops, manufactures, and commercializes UCART19, an allogeneic anti-CD19 chimeric antigen receptor (CAR) T cell product candidate for the treatment of patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma. In addition, it provides clinical-stage products, such as ALLO-501, cema-cel, ALLO-316, ALLO-329, ALLO-715, and ALLO-605; DLL3 for the treatment of small cell lung cancer; Claudin 18.2 for the treatment of gastric and pancreatic cancer; and FLT3 for the treatment of acute myeloid leukemia. The company has license and collaboration agreements with Pfizer Inc., Servier, Cellectis S.A., and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.

Last Close

1.55

Volume

2766631

Current Price

1.51

Change

-2.5806451612903247

Last Updated

2025-11-28T12:07:29.728Z

Image

data:image/webp;base64,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

Ipo Date

2018-10-11T00:00:00.000Z

Market Cap

319116800

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8488

Sentiment Sources

5

Rating

4.4286

Target Price

7.56

Strong Buy

8

Buy

4

Hold

2

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

31164000

Gross Profit

-31164000

Operating Expenses

13737000

Operating Income

-44901000

Interest Expense

344000

Pretax Income

-41400000

Net Income

-41400000

Eps

-0.18645399981660854

Dividends Per Share

-

Shares Outstanding

224730144

Income Tax Expense

-

EBITDA

-37959000

Operating Margin

-

Total Other Income Expense Net

3501000

Cash

37815000

Short Term Investments

214379000

Receivables

2100000

Inventories

-

Total Current Assets

260719000

Property Plant Equipment

116831000

Total Assets

439771000

Payables

3699000

Short Term Debt

8007999

Long Term Debt

-

Total Liabilities

124442000

Equity

315329000

Depreciation

3097000

Change In Working Capital

-145000

Cash From Operations

-29688000

Capital Expenditures

243000

Cash From Investing

11935000

Cash From Financing

3236000

Net Change In Cash

-14517000

PE

-

PB

1.0632653729913837

ROE

-13.129144480843818

ROA

-9.413990463218356

FCF

-29931000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

31164000

Quarters > 0 > income Statement > gross Profit

-31164000

Quarters > 0 > income Statement > operating Expenses

13737000

Quarters > 0 > income Statement > operating Income

-44901000

Quarters > 0 > income Statement > interest Expense

344000

Quarters > 0 > income Statement > pretax Income

-41400000

Quarters > 0 > income Statement > net Income

-41400000

Quarters > 0 > income Statement > eps

-0.18645399981660854

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

222038680

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-37959000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

3501000

Quarters > 0 > balance Sheet > cash

37815000

Quarters > 0 > balance Sheet > short Term Investments

214379000

Quarters > 0 > balance Sheet > receivables

2100000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

260719000

Quarters > 0 > balance Sheet > property Plant Equipment

116831000

Quarters > 0 > balance Sheet > total Assets

439771000

Quarters > 0 > balance Sheet > payables

3699000

Quarters > 0 > balance Sheet > short Term Debt

8007999

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

124442000

Quarters > 0 > balance Sheet > equity

315329000

Quarters > 0 > cash Flow > net Income

-41400000

Quarters > 0 > cash Flow > depreciation

3097000

Quarters > 0 > cash Flow > change In Working Capital

-145000

Quarters > 0 > cash Flow > cash From Operations

-29688000

Quarters > 0 > cash Flow > capital Expenditures

243000

Quarters > 0 > cash Flow > cash From Investing

11935000

Quarters > 0 > cash Flow > cash From Financing

3236000

Quarters > 0 > cash Flow > net Change In Cash

-14517000

Quarters > 0 > ratios > PE

-0.18645399981660854

Quarters > 0 > ratios > PB

1.0632653729913837

Quarters > 0 > ratios > ROE

-13.129144480843818

Quarters > 0 > ratios > ROA

-9.413990463218356

Quarters > 0 > ratios > FCF

-29931000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

3106000

Quarters > 1 > income Statement > gross Profit

-3106000

Quarters > 1 > income Statement > operating Expenses

56819000

Quarters > 1 > income Statement > operating Income

-56819000

Quarters > 1 > income Statement > interest Expense

268000

Quarters > 1 > income Statement > pretax Income

-50943000

Quarters > 1 > income Statement > net Income

-50943000

Quarters > 1 > income Statement > eps

-0.23269129482695503

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

218929548

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-47569000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

5876000

Quarters > 1 > balance Sheet > cash

52332000

Quarters > 1 > balance Sheet > short Term Investments

220788000

Quarters > 1 > balance Sheet > receivables

1700000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

282655000

Quarters > 1 > balance Sheet > property Plant Equipment

120824000

Quarters > 1 > balance Sheet > total Assets

470593000

Quarters > 1 > balance Sheet > payables

4851000

Quarters > 1 > balance Sheet > short Term Debt

7756000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

126032000

Quarters > 1 > balance Sheet > equity

344561000

Quarters > 1 > cash Flow > net Income

-50943000

Quarters > 1 > cash Flow > depreciation

3106000

Quarters > 1 > cash Flow > change In Working Capital

-2236000

Quarters > 1 > cash Flow > cash From Operations

-39030000

Quarters > 1 > cash Flow > capital Expenditures

44000

Quarters > 1 > cash Flow > cash From Investing

43835000

Quarters > 1 > cash Flow > cash From Financing

5072000

Quarters > 1 > cash Flow > net Change In Cash

9877000

Quarters > 1 > ratios > PE

-0.23269129482695503

Quarters > 1 > ratios > PB

0.9594342292946677

Quarters > 1 > ratios > ROE

-14.78490020634953

Quarters > 1 > ratios > ROA

-10.825277894061323

Quarters > 1 > ratios > FCF

-39074000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

3099000

Quarters > 2 > income Statement > gross Profit

-3099000

Quarters > 2 > income Statement > operating Expenses

62092000

Quarters > 2 > income Statement > operating Income

-65191000

Quarters > 2 > income Statement > interest Expense

150000

Quarters > 2 > income Statement > pretax Income

-59733000

Quarters > 2 > income Statement > net Income

-59733000

Quarters > 2 > income Statement > eps

-0.2773647723104212

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

215359000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-56484000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

5458000

Quarters > 2 > balance Sheet > cash

42455000

Quarters > 2 > balance Sheet > short Term Investments

237588000

Quarters > 2 > balance Sheet > receivables

2300000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

291576000

Quarters > 2 > balance Sheet > property Plant Equipment

127067000

Quarters > 2 > balance Sheet > total Assets

507982000

Quarters > 2 > balance Sheet > payables

5058000

Quarters > 2 > balance Sheet > short Term Debt

7631000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

122589000

Quarters > 2 > balance Sheet > equity

385393000

Quarters > 2 > cash Flow > net Income

-59733000

Quarters > 2 > cash Flow > depreciation

3099000

Quarters > 2 > cash Flow > change In Working Capital

-8294000

Quarters > 2 > cash Flow > cash From Operations

-52929000

Quarters > 2 > cash Flow > capital Expenditures

99000

Quarters > 2 > cash Flow > cash From Investing

6176000

Quarters > 2 > cash Flow > cash From Financing

13990000

Quarters > 2 > cash Flow > net Change In Cash

-32763000

Quarters > 2 > ratios > PE

-0.2773647723104212

Quarters > 2 > ratios > PB

0.8437934523979419

Quarters > 2 > ratios > ROE

-15.499243629230422

Quarters > 2 > ratios > ROA

-11.758881220200717

Quarters > 2 > ratios > FCF

-53028000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

-22000

Quarters > 3 > income Statement > cost Of Revenue

3233000

Quarters > 3 > income Statement > gross Profit

-3233000

Quarters > 3 > income Statement > operating Expenses

57257000

Quarters > 3 > income Statement > operating Income

-60490000

Quarters > 3 > income Statement > interest Expense

81000

Quarters > 3 > income Statement > pretax Income

-59496000

Quarters > 3 > income Statement > net Income

-59939000

Quarters > 3 > income Statement > eps

-0.2846484812795623

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

210572000

Quarters > 3 > income Statement > income Tax Expense

443000

Quarters > 3 > income Statement > EBITDA

-56182000

Quarters > 3 > income Statement > operating Margin

274954.54545454547

Quarters > 3 > income Statement > total Other Income Expense Net

994000

Quarters > 3 > balance Sheet > cash

75218000

Quarters > 3 > balance Sheet > short Term Investments

217258000

Quarters > 3 > balance Sheet > receivables

1900000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

303386000

Quarters > 3 > balance Sheet > property Plant Equipment

131261000

Quarters > 3 > balance Sheet > total Assets

548710000

Quarters > 3 > balance Sheet > payables

5394000

Quarters > 3 > balance Sheet > short Term Debt

7509000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

126531000

Quarters > 3 > balance Sheet > equity

422179000

Quarters > 3 > cash Flow > net Income

-59939000

Quarters > 3 > cash Flow > depreciation

3233000

Quarters > 3 > cash Flow > change In Working Capital

5270000

Quarters > 3 > cash Flow > cash From Operations

-36698000

Quarters > 3 > cash Flow > capital Expenditures

257000

Quarters > 3 > cash Flow > cash From Investing

54934000

Quarters > 3 > cash Flow > cash From Financing

5743000

Quarters > 3 > cash Flow > net Change In Cash

23979000

Quarters > 3 > ratios > PE

-0.2846484812795623

Quarters > 3 > ratios > PB

0.753149067101869

Quarters > 3 > ratios > ROE

-14.197532326335512

Quarters > 3 > ratios > ROA

-10.923620856189972

Quarters > 3 > ratios > FCF

-36955000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

1679.7727272727273

Quarters > 3 > health Score

52

Valuation > metrics > PE

-0.18645399981660854

Valuation > metrics > PB

1.0632653729913837

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-13.129144480843818

Profitability > metrics > ROA

-15.879164924689032

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3946417868321658

Risk > metrics > Interest Coverage

-130.52616279069767

Risk > final Score

-462

Risk > verdict

High

Liquidity > metrics > Current Ratio

22.27035297431904

Liquidity > metrics > Quick Ratio

22.27035297431904

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

30

Prev Risks > 0

-788

Prev Risks > 1

-1678

Prev Risks > 2

-2927

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:13:07.379Z